Menu
Knowledge Base
Presented by
Dr. Søren Skou
Søren Skou, PhD, is the managing director of Xenocs Nordic in Denmark, where he leads Xenocs developments in the biological a … Søren Skou, PhD, is the managing director of Xenocs Nordic in Denmark, where he leads Xenocs developments in the biological and pharmaceutical sectors. He got his Ph.D. at the Technical University of Denmark in the field of Biophysics and Small Angle X-ray Scattering (SAXS) and did two Post Docs, one of which was at the BioSAXS beamline at the Cornell High Energy Synchrotron Source in the US which included work with microfluidics and sample automation for biological samples. Soren has been engaged in the SAXS industry for more than 11 years with experience in both instrument design and development as well as sales and business development for biological applications of SAXS.

Key tools for understanding drug efficacy and stability

Webinar
23/10/2024
15:00

The development and production of biopharmaceuticals are advancing rapidly, with novel medicines becoming increasingly complex. From amorphous small molecules and fusion proteins to antibody-drug conjugates (ADCs) and viral & synthetic delivery vectors for cell & gene therapies, understanding the structure and composition of these entities is crucial for ensuring their efficacy and manufacturability.

Join us for the first webinar in a three-part series as we explore the complementary analytical solutions that will give you deeper insights into the structural features of your biopharmaceuticals. Together, technology and biopharmaceuticals industry experts from Malvern Panalytical and Xenocs will dive into applications around nucleic acid drug products (such as mRNA vaccines and RNA therapeutics), as well as biopharmaceuticals including peptide-based therapeutics.

Who should attend?

  • Scientists and researchers focused on the stability of biopharmaceuticals, including peptides and LNPs
  • Anyone involved in the development and production of nucleic acid drug products and biologics

What you will learn:

01

Gain insights into higher-order structural changes, thermal stability, and particle size distribution.

02

Learn how SAXS and DSC provide critical information on drug modalities.

03

Understand the importance of orthogonal approaches to the structure-property relationship of biopharmaceuticals.

Return

Access our
Knowledge base

Knowledge base